Clinical trial

Pharmacological and Behavioral Treatment After Bariatric Surgery

NCT05157698

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-01-13

PhasePHASE3

Study timeline

Study start (actual)2022-01-13Date precision: day

Registry last updated2026-09-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Naltrexone and Bupropion CombinationDRUG

Behavioral Weight LossBEHAVIORAL

PlaceboOTHER

Sponsors & collaborators

Yale Universitylead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05157698 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.